Global Interventional Imaging Market Size Study, by Offering (Interventional Imaging Systems, Interventional Imaging Software, Consumables), Application (Cardiology, Neurology, Musculoskeletal, Oncology, Urology, Gastroenterology, Obstetrics, Gynaecology,

Global Interventional Imaging Market Size Study, by Offering (Interventional Imaging Systems, Interventional Imaging Software, Consumables), Application (Cardiology, Neurology, Musculoskeletal, Oncology, Urology, Gastroenterology, Obstetrics, Gynaecology, Others), End User (Hospitals, Ambulatory Surgical Centres, Clinics) and Regional Forecasts 2022-2032

The Global Interventional Imaging Market is valued at approximately USD 9.24 billion in 2023 and is anticipated to grow with a healthy growth rate of over 6.71% over the forecast period 2024-2032. Interventional imaging is the use of various imaging technologies to guide minimally invasive surgical procedures and diagnostic interventions. This technique is integral to interventional radiology, where imaging modalities such as X-ray, ultrasound, CT (computed tomography), and MRI (magnetic resonance imaging) are used to visualize the inside of the body in real time. This allows physicians to accurately guide instruments through small incisions or natural body openings to diagnose or treat medical conditions.

The increasing demand for minimally invasive procedures, coupled with the growing adoption of new technologies and the rising prevalence of chronic diseases, are significant factors driving the expansion of the Interventional Imaging Market. This market includes various procedures, consumables, systems, and software designed for the diagnosis and treatment of chronic diseases, making it a cornerstone in the evolution of medical diagnostics and treatment. Recent years have witnessed notable improvements and innovations in imaging technologies, particularly with the advent of 3D and 4D imaging and high-quality 4K imaging systems. These advancements have transformed the market, offering faster, more efficient, and cost-effective imaging solutions that enhance patient care and treatment outcomes. Interventional imaging technology has not only supported but catalyzed numerous breakthroughs in both diagnosis and treatment, promising more revolutionary findings in the future.

The key regions considered in the study of Global Interventional Imaging Market include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa Regionally, North America held the dominating position in 2023, owing to factors such as the increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, and neurological disorders necessitates advanced diagnostic and therapeutic procedures, boosting the demand for interventional imaging. Moreover, technological advancements in imaging modalities, such as the development of high-resolution and 3D imaging systems, enhance the precision and effectiveness of minimally invasive procedures, attracting healthcare providers to adopt these technologies. Additionally, the rising geriatric population, which is more susceptible to chronic conditions, contributes to the growing demand for interventional imaging. while the Asia-Pacific region is expected to register the fastest growth during the forecast period 2024-2032. The economic growth in countries like China and India, coupled with increasing healthcare spending and technological advancements, presents substantial opportunities for market expansion in the Asia-Pacific region.

Major market players included in this report are:

Becton, Dickinson and Company

Canon Inc.

Esaote SpA

FUJIFILM Holdings Corporation

GE HealthCare

Hologic, Inc.

Intuitive Surgical, Inc.

Koninklijke Philips NV

Medtronic plc

Siemens Healthineers AG

Stryker Corporation

Shimadzu Corporation

Terumo Corporation

Trivitron Healthcare

Hitachi Medical Systems

The detailed segments and sub-segment of the market are explained below:

By Offering:

Interventional Imaging Systems

Interventional Imaging Software

Consumables

By Application:

Cardiology

Neurology

Musculoskeletal

Oncology

Urology

Gastroenterology

Obstetrics

Gynaecology

Others

By End User:

Hospitals

Ambulatory Surgical Centres

Clinics

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Italy

Spain

ROE

Asia Pacific

China

India

Japan

Australia

RoAPAC

Latin America

Brazil

Mexico

RoLA

Middle East & Africa

Saudi Arabia

South Africa

RoMEA

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.

Annualized revenues and regional level analysis for each market segment.

Detailed analysis of geographical landscape with Country level analysis of major regions.

Competitive landscape with information on major players in the market.

Analysis of key business strategies and recommendations on future market approach.

Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.